Apolipoprotein (APO)E Genotype, Meal Fatty Acids, Postprandial Lipaemia
Effects of Meal Fatty Acid Composition on Postprandial Lipaemia in Men According to APOE Genotype
1 other identifier
interventional
31
1 country
1
Brief Summary
Cardiovascular disease (CVD) is the greatest cause of morbidity and mortality in the UK. Abnormalities in the concentration and/or composition of lipoproteins (the lipid carrying particles), in particular low density lipoproteins (LDL) in circulation, is one of the most important physiological defects contributing to the development of CVD. The LDL cholesterol (LDLC) response to fatty acid change is in part mediated by the APOE genotype, with E4 individuals (25% of the UK population) being most responsive to changes in dietary fats, showing greater reductions when low levels of saturated fats or fish oils are consumed and greater increases when high levels of these fats are consumed. Therefore the aims of the present study is to understand the mechanism that regulates the higher LDLC response associated with saturated fatty acids and fish oil consumption in healthy men prospectively recruited based on their APOE genotype.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Mar 2009
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFirst Submitted
Initial submission to the registry
January 26, 2012
CompletedFirst Posted
Study publicly available on registry
January 31, 2012
CompletedFebruary 2, 2012
January 1, 2012
9 months
January 26, 2012
January 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Impact of APOE genotype and dietary fat composition in plasma lipids
3 months
Secondary Outcomes (1)
Cardiovascular disease risk factors
3 months
Study Arms (3)
High saturated fat meal
EXPERIMENTALSaturated fatty acid and fish oils meal
EXPERIMENTALEquivalent to two portions of oily fish
High unsaturated fat meal
ACTIVE COMPARATORProvided a fatty acid profile representative of a typical UK diet
Interventions
Volunteers consumed a single test meal breakfast containing 53 g of fat, of which 50 g was substituted for saturated fats.
Volunteers consumed a single test meal breakfast containing 53 g of fat, of which 50 g was substituted for saturated fats and fish oil. The dose of fish oils was equivalent to two portions of oily fish.
Volunteers consumed a single test meal breakfast containing 53 g of fat, of which 50 g was substituted for unsaturated fats. It provided a fatty acid profile representative of a typical UK diet.
Eligibility Criteria
You may qualify if:
- Gender Male
- Age 18-70 years
- Body Mass Index (BMI) \< 32 kg/m2
- Plasma triglycerides 1-4 mmol/l
- Plasma cholesterol \< 8 mmol/l
- Glucose \< 7 mmol/l
- Haemoglobin \> 11 g/dl
- ApoE E3/E3, E3/E4
You may not qualify if:
- Blood pressure \> 200/95 mmHg
- Had suffered a myocardial infraction or stroke in previous 2 years.
- Diabetes mellitus
- Liver disease
- Other endocrine disorders
- Unstable angina
- Familial hyperlipidaemia
- Any dietary restrictions or an a weight reducing diet
- On fatty acid supplements e.g. evening primrose oil or fish oils
- Vigorous exercise e.g. competitive athletes
- ApoE2/E2, apoE2/E3 and apoE2/E4
- Any other parameter on which the investigators felt an individual was unsuitable
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Readinglead
- Unilever R&Dcollaborator
Study Sites (1)
Department of Food and Nutritional Sciences, University of Reading
Reading, United Kingdom
Related Publications (2)
Calabuig-Navarro MV, Jackson KG, Kemp CF, Leake DS, Walden CM, Lovegrove JA, Minihane AM. A randomized trial and novel SPR technique identifies altered lipoprotein-LDL receptor binding as a mechanism underlying elevated LDL-cholesterol in APOE4s. Sci Rep. 2017 Mar 9;7:44119. doi: 10.1038/srep44119.
PMID: 28276521DERIVEDCalabuig-Navarro MV, Jackson KG, Walden CM, Minihane AM, Lovegrove JA. Apolipoprotein E genotype has a modest impact on the postprandial plasma response to meals of varying fat composition in healthy men in a randomized controlled trial. J Nutr. 2014 Nov;144(11):1775-80. doi: 10.3945/jn.114.197244. Epub 2014 Sep 17.
PMID: 25332476DERIVED
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Julie A Lovegrove, Professor
University of Reading
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 26, 2012
First Posted
January 31, 2012
Study Start
March 1, 2009
Primary Completion
December 1, 2009
Study Completion
July 1, 2011
Last Updated
February 2, 2012
Record last verified: 2012-01